LifeWatch AG

EANS-Adhoc: +++ Reminder +++ LifeWatch AG to report on positive Q2 2010 results on Thursday, July 29, 2010

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this

6-month report/LifeWatch AG


- 07:00 a.m. CEST: Press release/Letter to Shareholders; - 10:00 a.m. CEST: Analyst/Media Conference; Conference Call/Webcast;

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE) will report on its positive second quarter 2010 results on Thursday, July 29, 2010, by issuing a Press Release and Letter to Shareholders at 07:00 a.m. CEST and hosting an English-speaking Analyst and Media Conference at 10:00 a.m. CEST at Zunfthaus zur Saffran, Limmatquai 54, 8001 Zürich/Switzerland. Please register for the live Zürich conference by email to The conference is also accessible as a conference call/webcast at:

+ 41 (0)91 610 56 00 (Europe); + 44 (0)207 107 06 11 (UK); + 1(1)866 291 41 66 (USA - Toll-free);

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home SleepTesting of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit

Sign-up for customized E-mail alerts and documentation requests is available at

end of announcement                               euro adhoc

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email

Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard

Original-Content von: LifeWatch AG, übermittelt durch news aktuell

Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: